AstraZeneca Pharma India Ltd Appoints Dr. Shashank Srinivasan as Medical Director – Oncology Business Unit and Promotes Mr. Venkat Natarajan to Director – Market Access Business Unit

AstraZeneca Pharma India Ltd has appointed Dr. Shashank Srinivasan as Medical Director – Oncology Business Unit and promoted Mr. Venkat Natarajan to Director – Market Access Business Unit. Dr. Shashank Srinivasan is a clinical oncologist with a DNB in Radiation Oncology from Max Super Speciality Hospital, Vaishali. He has a strong scientific grounding and has contributed to oncology research. Mr. Venkat Natarajan is a seasoned Market Access professional with demonstrated leadership in Access strategy, Pricing and Patient Affordability Initiatives. He has been instrumental in building and strengthening the Market Access function and has driven strategic access initiatives, expanded patient support programs, and advanced state-level access models.